Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rare cancers, CTLA-4, Ipilimumab, Skin cancer (all types) and the tags skin, rare.
Shares Skin cancer after an organ transplant, Advanced cutaneous squamous cell carcinoma, Cutaneous squamous cell carcinoma, Skin cancer (all types) and the tag skin.
Shares BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors, Sandra P. D'Angelo, TCR-T cell therapy, p53 / RB / cell-cycle checkpoint and the tag rare.
Shares Why nobody knows how many skin cancers there are: the counting rule behind every figure, Keratinocyte cancer (and why 'non-melanoma skin cancer' is being retired), How skin carcinoma is staged in Britain: UICC TNM, and why it is not the American system, What makes a skin cancer high risk: the UK feature lists and the tag skin.
Shares Avelumab, Rare cancers, PD-1 / PD-L1 immune checkpoint & T-cell activation, Pfizer (incl. Seagen) and the tag rare.
Shares Rare cancers, Immune-related adverse events (irAEs), Tumour mutational burden (TMB), Pfizer (incl. Seagen) and the tag rare.
Shares Platinum + etoposide (EP / CE), Rare cancers, Nivolumab, PD-1 and the tag rare.
Shares Rare cancers, p53 / RB / cell-cycle checkpoint, Merck & Co. (MSD), PD-1 and the tag rare.
The same record for scripts and assistants; checked 2026-09-25. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.